Response scale selection in adult pain measures: results from a literature review.

Autor: Safikhani S; 1Evidera, 7101 Wisconsin Ave., Suite 1400, Bethesda, MD 20814 USA., Gries KS; 2Janssen Global Services LLC, 700 Route US 202, Raritan, NJ 08869 USA., Trudeau JJ; 2Janssen Global Services LLC, 700 Route US 202, Raritan, NJ 08869 USA., Reasner D; 3Ironwood Pharmaceuticals, 301 Binney Street, Cambridge, MA 02142 USA., Rüdell K; 4Pfizer LTD, Outcomes & Evidence, Global Health & Value, Pfizer Ltd, Tadworth, Surrey UK., Coons SJ; 5Patient-Reported Outcome Consortium, Critical Path Institute, 1730 E River Rd, Tucson, AZ 85718 USA., Bush EN; 6Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285 USA., Hanlon J; 3Ironwood Pharmaceuticals, 301 Binney Street, Cambridge, MA 02142 USA., Abraham L; 4Pfizer LTD, Outcomes & Evidence, Global Health & Value, Pfizer Ltd, Tadworth, Surrey UK., Vernon M; 1Evidera, 7101 Wisconsin Ave., Suite 1400, Bethesda, MD 20814 USA.
Jazyk: angličtina
Zdroj: Journal of patient-reported outcomes [J Patient Rep Outcomes] 2018 Sep 06; Vol. 2, pp. 40. Date of Electronic Publication: 2018 Sep 06 (Print Publication: 2017).
DOI: 10.1186/s41687-018-0053-6
Abstrakt: Background: The purpose of this literature review was to examine the existing patient-reported outcome measurement literature to understand the empirical evidence supporting response scale selection in pain measurement for the adult population.
Methods: The search strategy involved a comprehensive, structured, literature review with multiple search objectives and search terms.
Results: The searched yielded 6918 abstracts which were reviewed against study criteria for eligibility across the adult pain objective. The review included 42 review articles, consensus guidelines, expert opinion pieces, and primary research articles providing insights into optimal response scale selection for pain assessment in the adult population. Based on the extensive and varied literature on pain assessments, the adult pain studies typically use simple response scales with single-item measures of pain-a numeric rating scale, visual analog scale, or verbal rating scale. Across 42 review articles, consensus guidelines, expert opinion pieces, and primary research articles, the NRS response scale was most often recommended in these guidance documents. When reviewing the empirical basis for these recommendations, we found that the NRS had slightly superior measurement properties (e.g., reliability, validity, responsiveness) across a wide variety of contexts of use as compared to other response scales.
Conclusions: Both empirical studies and review articles provide evidence that the 11-point NRS is likely the optimal response scale to evaluate pain among adult patients without cognitive impairment.
Competing Interests: This article does not contain any studies with human participants or animals performed by any of the authors.Not applicable.SJC reports no employment in a pharmaceutical company nor does he hold stocks, shares, or stock options in a pharmaceutical company. LA is an employee and owns stocks, shares, and stock options for Pfizer Ltd. KG reports she is a current employee at Janssen but reports no stocks, shares, nor options. ENB works for Eli Lilly & Company and holds stocks or shares there, but no stock options. JTH and DSR are salaried employees and own stocks, shares, and stock options at Ironwood Pharmaceuticals. KR is an employee of Shire and owns stock options there. JT is a current employee at Janssen but reports no stocks, shares, nor options. SS and MV are employees of Evidera, a research and consulting firm to the biopharma industry and, as such, are not allowed to accept remuneration from any Evidera clients. None of these authors report any other arrangements that could be perceived as conflicts of interest.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Databáze: MEDLINE
Externí odkaz: